Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

685
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
685
Dementia l: Introduction01:22

Dementia l: Introduction

29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
Association Areas of the Cortex01:21

Association Areas of the Cortex

10.1K
Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
10.1K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

19
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

27
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
27

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining and Measuring Cognitive Decline and Clinical Relevance.

Neurology and therapy·2026
Same author

Head-to-head comparison of neurodegeneration biomarkers across two analytical platforms in Alzheimer's disease.

Aging clinical and experimental research·2026
Same author

Characterising anthelmintic resistance to benzimidazoles and macrocyclic lactones in gastrointestinal nematodes of dairy cattle.

International journal for parasitology. Drugs and drug resistance·2026
Same author

Estimation of positron emission tomography amyloid load and related biomarkers in Alzheimer's disease using evoked potential tomography EEG: development and internal validation in a cross-sectional cohort.

Alzheimer's research & therapy·2026
Same author

Exercise Therapy to Reduce Anxiety (ExTRA) in mid-life and later-life adults: pilot feasibility study.

BJPsych open·2026
Same author

Feasibility of short imaging protocols for [<sup>18</sup>F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophy.

European journal of nuclear medicine and molecular imaging·2026

Related Experiment Video

Updated: Apr 26, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K

What is frontotemporal dementia?

Alexander Kurz1, Carolin Kurz2, Kathryn Ellis3

  • 1Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Maturitas
|July 26, 2014
PubMed
Summary
This summary is machine-generated.

Frontotemporal dementia (FTD) involves nerve cell loss in brain lobes, causing early-onset dementia. Diagnosis requires clinical exams and imaging, with management focusing on non-pharmacological approaches.

Keywords:
Frontotemporal dementiadiagnosisgeneticsmanagementneuropathology

More Related Videos

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

13.9K

Related Experiment Videos

Last Updated: Apr 26, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.2K
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

27.9K
Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
08:29

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans

Published on: December 18, 2016

13.9K

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Frontotemporal dementia (FTD) is a progressive neurodegenerative disorder.
  • It is the second most common cause of early-onset dementia.
  • FTD affects frontal and temporal lobes, leading to nerve cell loss.

Purpose of the Study:

  • To provide a comprehensive overview of Frontotemporal Dementia (FTD).
  • To detail the clinical manifestations, pathology, diagnosis, and management of FTD.
  • To highlight the challenges in FTD treatment and current therapeutic strategies.

Main Methods:

  • Review of clinical characteristics of FTD variants (behavioral and language).
  • Description of histopathological findings, including protein abnormalities (Tau, TDP-43, FUS).
  • Summary of diagnostic approaches and management strategies, emphasizing interdisciplinary care.

Main Results:

  • FTD presents with distinct behavioral (disinhibition, apathy) or language (agrammatism, anomia) syndromes.
  • Pathology involves abnormal protein processing (Tau, TDP-43, FUS) and genetic mutations.
  • Diagnosis relies on clinical assessment, neuroimaging, and laboratory tests.

Conclusions:

  • FTD management necessitates an interdisciplinary approach, prioritizing non-pharmacological interventions.
  • Current dementia drugs show limited efficacy in FTD.
  • Selective serotonergic antidepressants may help behavioral symptoms, while antipsychotics require cautious use.